Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model

Jakob Appel Østergaard, Mette Bjerre, Satish Posettihalli RamachandraRao, Anoop Kumar Sharma, Jens Randel Nyengaard, Troels Krarup Hansen, Steffen Thiel, Allan Flyvbjerg

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Abstract

BACKGROUND. Mannan-binding lectin (MBL) is involved in the development of diabetic nephropathy. MBL is a part of the innate immune system where it can activate the complement system. Serum MBL level predicts later renal impairment in diabetes patients. Direct involvement of MBL in the development of diabetic kidney disease is observed in one animal strain. However, this involvement may differ among the animal strains. We thus examined the impact of the genetic background on the role of MBL in diabetic nephropathy.
OriginalsprogEngelsk
TidsskriftExperimental Diabetes Research
Vol/bind2012
Sider (fra-til)678381
ISSN1687-5214
DOI
StatusUdgivet - 2012

Fingeraftryk

Dyk ned i forskningsemnerne om 'Mannan-binding lectin in diabetic kidney disease: the impact of mouse genetics in a type 1 diabetes model'. Sammen danner de et unikt fingeraftryk.

Citationsformater